Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism

INTRODUCTION: Human epidermal growth factor 2 (Her2), a receptor tyrosine kinase, is overexpressed in breast cancers. It has been successfully targeted by small molecule kinase inhibitors and by antibodies. Recent clinical data show a synergistic response in patients when two antibodies, trastuzumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218942/
https://www.ncbi.nlm.nih.gov/pubmed/21600050
http://dx.doi.org/10.1186/bcr2888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218942/
https://www.ncbi.nlm.nih.gov/pubmed/21600050
http://dx.doi.org/10.1186/bcr2888

Ejemplares similares